Selection of Solubility Enhancement Technologies for S-892216, a Novel COVID-19 Drug Candidate. - Ohashi R; Otake S; Murata T; Watari R; Yoshida S; Kitade M; Kondo D; Kimura G (Pharmaceutics, 2025)